Clive R. Seed

3.6k citations

96 papers · 2.0k indexed · h-index 25

Hepatology top 1%
- Hepatitis C virus research 26
Management of Technology and Innovation top 0.5%
- Blood donation and transfusion practices 28
Infectious Diseases top 2%
- Viral Infections and Vectors 17
- HIV/AIDS Research and Interventions 12
Epidemiology top 2%
- Hepatitis B Virus Studies 26
- HIV, Drug Use, Sexual Risk 19
Public Health, Environmental and Occupational Health top 5%
- Mosquito-borne diseases and control 23
- Malaria Research and Control 11

Co-authors: A. J. Keller Philip Kiely T.J. Cobain E. A. C. Follett Tom Krusius P.L. Yap F. McOmish Elina Kolho
Cited by: Hepatology Management of Technology and Innovation Infectious Diseases
Journals: Journal of Clinical Microbiology (1 paper)Emerging infectious diseases (1 paper)American Journal of Transplantation (1 paper)
Partner nations: Australia United States United Kingdom

In The Last Decade

Clive R. Seed

90 papers receiving 2.0k citations

Peers

Countries citing papers authored by Clive R. Seed

Since Specialization

Citations

This map shows the geographic impact of Clive R. Seed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clive R. Seed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clive R. Seed more than expected).

Fields of papers citing papers by Clive R. Seed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clive R. Seed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clive R. Seed. The network helps show where Clive R. Seed may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Clive R. Seed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Clive R. Seed Line = papers co-authored together Clive R. Seed links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Removal of UK‐donor deferral for variant Creutzfeldt–Jakob disease: A large donation gain in Australia Vox Sanguinis ·Veronica C. Hoad,Clive R. Seed,Philip Kiely,Claire E. Styles,Hamish McManus,Matthew Law,John Kaldor,Iain B. Gosbell	2023	2
2	Is dual testing for hepatitis C necessary? Modelling the risk of removing hepatitis C antibody testing for Australian blood donations Vox Sanguinis ·Avijoy Roy Choudhury,Veronica C. Hoad,Clive R. Seed,P.J. Bentley	2023	2
3	Removing hepatitis C antibody testing for Australian blood donations: A cost‐effectiveness analysis Vox Sanguinis ·Qinglu Cheng,Veronica C. Hoad,Avijoy Roy Choudhury,Clive R. Seed,P.J. Bentley,Sophy Shih,Jisoo A. Kwon,Richard T. Gray,Virginia Wiseman	2023	3
4	Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review Transfusion Medicine and Hemotherapy ·Philip Kiely,Veronica C. Hoad,Clive R. Seed,Iain B. Gosbell	2022	3
5	HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men Vox Sanguinis ·Eliana Aubé,Antoine Lewin,Sheila F. O’Brien,Yves Grégoire,Josiane Pillonel,Whitney R. Steele,Brian Custer,Katy Davison,Marc Germain,Clive R. Seed,Félix Camirand Lemyre,(unknown)	2021	6
6	Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review medRxiv ·Sahar Saeed,Samra Uzicanin,Antoine Lewin,Ryanne W. Lieshout‐Krikke,Helen M. Faddy,Christian Erikstrup,Carla Osiowy,Clive R. Seed,Whitney R. Steele,Katy Davidson,Brian Custer,Sheila F. O’Brien	2021	4
7	Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review Vox Sanguinis ·Sahar Saeed,Samra Uzicanin,Antoine Lewin,Ryanne W. Lieshout‐Krikke,Helen M. Faddy,Christian Erikstrup,Carla Osiowy,Clive R. Seed,Whitney R. Steele,Katy Davison,Brian Custer,Sheila F. O’Brien,(unknown)	2021	6
8	Effect of HIV pre‐exposure prophylaxis (PrEP) on detection of early infection and its impact on the appropriate post‐PrEP deferral period Vox Sanguinis ·Clive R. Seed,Claire E. Styles,Veronica C. Hoad,Hung‐Chih Yang,Michael J. Thomas,Iain B. Gosbell	2020	18
9	Excluding Occult Hepatitis B Infection before Assigning False-Positive Status to Non-Repeatable NAT Reactivity: Concerning Stolz et al. “Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country” [Transfus Med Hemother. 2019 Apr;46(2):104–10] Transfusion Medicine and Hemotherapy ·Claire E. Styles,Anthea Cheng,Veronica C. Hoad,Philip Kiely,Michael Watson,Clive R. Seed	2019	3
10	Undetectable does not equal untransmittable for HIV and blood transfusion Vox Sanguinis ·Iain B. Gosbell,Veronica C. Hoad,Claire E. Styles,June Lee,Clive R. Seed	2019	13
11	Changing the deferral for men who have sex with men – an improved model to estimate HIV residual risk Vox Sanguinis ·Katy Davison,Yves Grégoire,Marc Germain,Brian Custer,Sheila F. O’Brien,Whitney R. Steele,Josiane Pillonel,Clive R. Seed,(unknown)	2019	15
12	HIV residual risk in Canada under a three‐month deferral for men who have sex with men Vox Sanguinis ·Sheila F. O’Brien,Yves Grégoire,Josiane Pillonel,Whitney R. Steele,Brian Custer,Katy Davison,Marc Germain,Antoine Lewin,Clive R. Seed,(unknown)	2019	23
13	Confirming transfusion‐transmitted viral infections in the molecular age: time to get back to the basic definition of infection for hemovigilance Transfusion ·Veronica C. Hoad,Claire E. Styles,Clive R. Seed,Philip Kiely,Iain B. Gosbell	2019	0
14	Blood safety assessment of hepatitis A outbreak linked to frozen pomegranate arils: are foodborne outbreaks an emerging blood safety risk? Transfusion ·Claire E. Styles,Veronica C. Hoad,Philip Kiely,Clive R. Seed,Iain B. Gosbell	2019	0
15	Modelling the risk of transfusion‐transmitted syphilis: a reconsideration of blood donation testing strategies Vox Sanguinis ·Thisuri Jayawardena,Veronica C. Hoad,Claire E. Styles,Clive R. Seed,P.J. Bentley,Vanessa Clifford,Sarina Lacey,Tessa Gastrell	2018	14
16	Estimation of human T‐lymphotropic virus incidence in blood donors from observed prevalence Vox Sanguinis ·Claire E. Styles,Veronica C. Hoad,Clive R. Seed	2018	6
17	Hepatitis E virus infections in travellers: assessing the threat to the Australian blood supply. PubMed ·Ashish C. Shrestha,Robert L. Flower,Clive R. Seed,A. J. Keller,Veronica C. Hoad,Robert Harley,Robyn Leader,Ben Polkinghorne,Catriona Furlong,Helen M. Faddy	2017	4
18	Reconsideration of blood donation testing strategy for human T‐cell lymphotropic virus in Australia Vox Sanguinis ·Claire E. Styles,Clive R. Seed,Veronica C. Hoad,Silvana Gaudieri,A. J. Keller	2017	18
19	The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries Transfusion Medicine Reviews ·Sheila F. O’Brien,Gilles Delage,Clive R. Seed,Josiane Pillonel,Cécile Fabra,Katy Davison,Alan D. Kitchen,Whitney R. Steele,David A. Leiby	2015	44
20	Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus Internal Medicine Journal ·Clive R. Seed,Philip Kiely,A. J. Keller	2005	72

About Clive R. Seed

Clive R. Seed is a scholar working on Hepatology, Management of Technology and Innovation and Infectious Diseases, having authored 96 papers that have together received 2.0k indexed citations. Recurring topics across this work include Blood donation and transfusion practices (28 papers), Hepatitis B Virus Studies (26 papers), Hepatitis C virus research (26 papers), Mosquito-borne diseases and control (23 papers), HIV, Drug Use, Sexual Risk (19 papers), Viral Infections and Vectors (17 papers), HIV/AIDS Research and Interventions (12 papers) and Malaria Research and Control (11 papers). The work is most often cited by research in Hepatology (950 citations), Management of Technology and Innovation (516 citations) and Infectious Diseases (627 citations). Clive R. Seed has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include A. J. Keller, Philip Kiely, T.J. Cobain, E. A. C. Follett, Tom Krusius, P.L. Yap, F. McOmish, Elina Kolho, B. C. Dow and R. Naukkarinen. Their work appears in journals such as Journal of Clinical Microbiology, Emerging infectious diseases and American Journal of Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact